Mark Christopher Capone, President, MGL at MYRIAD GENETICS INC (MYGN), sold 19,805 shares at $27.00 ($535K) on 2012-09-10, disclosed to the SEC on 2012-09-12.
Scheduled sale ($535k) by President, MGL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.00 | 1,251 | $34K | 6.3% |
| 2 | $27.00 | 4,450 | $120K | 22.5% |
| 3 | $27.00 | 14,104 | $381K | 71.2% |
| Total | $27.00 avg | 19,805 | $535K | 100% |
| Filing → |
| MYGN | SELL | 2018-07-13 | $3.3M | — | Filing → |
| MYGN | SELL | 2018-06-01 | $3.4M | — | Filing → |
| MYGN | BUY | 2016-08-19 | $425K | — | Filing → |